Make a donation today

100 percent of all donations to Project Mine will go directly towards the mapping and analysis of DNA profiles.

Ulm Neurology Department and Ulm ALS Research Center

The Ulm Neurology Department and the Ulm ALS Research Center, supported by the Charcot Foundation for ALS Research, combine the diagnosis and care for ALS patients with intensive clinical and basic research activities. Clinical research includes studies of imaging, electrophysiology, biomarkers as well as neuropsychology. The Ulm Neurology Department is conducting multi-center clinical ALS trials on a regular basis. Moreover, the Ulm ALS Research Center coordinates ALS research networks including the German ALS Network (MND-NET) or the epidemiological ALS registry in Swabia. Basic research includes molecular genetics, neuropathology, small animal models of ALS as well as the use of induced pluripotent stem cells (iPSCs) to decipher disease mechanisms and ultimately find novel therapeutic targets and therapies.

Importantly, a large ALS biomaterial bank has been built up in Ulm during the past almost 20 years. This collection of blood, cerebrospinal fluid or tissue represents a most valuable resource for researchers. It comprises also a large collection of DNA samples from ALS patients, which will allow important discoveries towards a better understanding and treatment of ALS. Your donation will be crucial to investigate the DNA that our patients have contributed and to discover the genetic factors involved in ALS.

staff

May we introduce our experts?

Project MinE research in Germany is performed at the Ulm Neurology Department of Ulm University.

  • Albert Ludolph

    Head of the Department of Neurology of Universitätsklinikum Ulm

    Albert Ludolph

    Head of the Department of Neurology of Universitätsklinikum Ulm

    Prof. Dr. Albert C. Ludolph is the head of the Department of Neurology of Universitätsklinikum Ulm.

  • Jochen Weishaupt

    Senior Neurologist, Group leader Exp. Neurology Ulm University

    Jochen Weishaupt

    Senior Neurologist, Group leader Exp. Neurology Ulm University

    Dr. Weishaupt studied at the Heidelberg Medical School from 1992-1998, earning his MD (summa cum laude) investigating glutamate receptor neurobiology in the laboratories of Peter H. Seeburg (ZMBH) and Bert Sakmann. Jochen Weishaupt joined the laboratory of Mathias Baehr in Tuebingen and graduated from Tuebingen Medical School in 1999. He spent part of his practical year in the Massachusetts General Hospital, Harvard Medical School, and the Beth Israel Medical Centre, Albert Einstein College, New York. Since 1999, Jochen Weishaupt has participated in a combined clinical and research training program and established his own research team in the Department of Neurology. He specialized in neurology in 2007, and finished his Habilitation (permission to teach at the University of Göttingen, faculty member) in 2008. He has also been Consultant/Attending Physician since 2009. Jochen Weishaupt’s scientific interests are neuronal cell death and the development of neuroprotective strategies for neurodegenerative diseases.

Our partners

In Germany fundraising for Project MinE is led by the Charcot Stiftung.